Pityriasis rosea-like eruption during treatment with imatinib mesylate: Description of 3 cases

Journal of the American Academy of Dermatology

Volumn 53, Issue 5 SUPPL., 2005, Pages

  Brazzelli, Valeria ^a,b   Prestinari, Francesca ^a   Roveda, Elena ^a   Barbagallo, Tania ^a   Bellani, Eleonora ^a   Vassallo, Camilla ^a   Orlandi, Ester ^b   Passamonti, Francesco ^b   Borroni, Giovanni ^a  

^a Institute of Dermatology   (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; IMATINIB; STEROID;

ADULT; ARTICLE; CASE REPORT; CHRONIC MYELOID LEUKEMIA; DESQUAMATION; DRUG ERUPTION; DRUG WITHDRAWAL; ERYTHEMA; HISTOLOGY; HUMAN; MALE; PITYRIASIS ROSEA; PRIORITY JOURNAL; PRURITUS; RASH;

ADULT; ANTINEOPLASTIC AGENTS; HUMANS; LEUKEMIA, MYELOID, CHRONIC; MALE; MIDDLE AGED; PIPERAZINES; PITYRIASIS ROSEA; PYRIMIDINES;

EID: 26644437437     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2004.10.888     Document Type: Article

References (23)

1. S. Faderl, M. Talpaz, Z. Estrov, S. O'Brien, R. Kurzrock, and H.M. Kantarjian The biology of chronic myeloid leukemia N Engl J Med 341 1999 164 172
2. M. Sattler, and J.D. Griffin Molecular mechanism of transformation by the bcr-abl oncogene Semin Hematol 40 2003 4 10
3. B.J. Druker, M. Talpaz, D.J. Resta, B. Peng, E. Buchdunger, and J.M. Ford Efficacy and safety of a specific inhibitor of the bcr-abl tyrosine kinase in chronic myeloid leukaemia N Engl J Med 344 2001 1031 1037
4. B.J. Druker, C.L. Sawyers, and H. Kantarjian Activity of a specific inhibitor of the bcr-abl tyrosine kinase in the blast crisis of chronic myeloid leukaemia and acute lymphoblastic leukaemia with the Philadelphia chromosome N Engl J Med 344 2001 1038 1042
5. M.J. Mauro, M. O'Dwyer, M.C. Heinrich, and B.J. Druker STI571: A paradigm of new agents for cancer therapeutics J Clin Oncol 20 2002 325 334
6. M. Brouard, and J.H. Sauart Cutaneous reactions to STI571 N Engl J Med 345 2001 618 619
7. L. Valeyrie, S. Bustuji-Garin, J. Revuz, N. Bachot, J. Wechsler, and P. Berthaud Adverse cutaneous reactions to imatinib (STI571) in Philadelphia chromosome-positive leukemias: a prospective study of 54 patients J Am Acad Dermatol 48 2003 201 206
8. M. Brouard, C. Prins, S. Mach-Pascual, and J.H. Saurat Acute generalized exanthematous pustulosis associated with STI571 in a patient with chronic myeloid leukaemia Dermatology 203 2001 57 59
9. M. Schwarz, K.A. Kreuzer, G. Baskaynak, B. Dorken, and P. le Coutre Imatinib-induced acute generalized exanthematous pustulosis (AGEP) in two patients with chronic myeloid leukaemia Eur J Haematol 69 2002 254 256
10. S.H. Clark, M. Duvic, and V.G. Prieto Mycosis fungoides-like reactions in a patient treated with Gleevec J Cutan Pathol 30 2003 279 281
11. L.T. Hsiao, H.M. Chung, J.T. Lin, T.J. Chiou, J.H. Liu, and F.S. Fan Steven-Johnson syndrome after treatment with STI571: a case report Br J Hematol 117 2002 620 622
12. D.S. Lim, and J. Muir Oral lichenoid reaction to Imatimib (STI571, Gleevec) Dermatology 205 2002 169 171
13. P. Raanani, J.M. Goldman, and I. Ben-Bassat Depigmentation in a chronic myeloid leucemia patient treated with STI-571 J Clin Oncol 20 2002 869 870
14. S. Hasan, K. Dinh, F. Lombardo, F. Dawkins, and J. Kark Hypopigmentation in an African patient treated with imatinib mesylate: a case report J Natl Med Assoc 95 2003 722 724
15. A.S. Tsao, H. Kantarjian, J. Cortes, S. O'Brien, and M. Talpaz Imatinib mesylate causes hypopigmentation in the skin Cancer 98 2003 2483 2487
16. K. Konstantopoulos, A. Papadogianni, M. Dimopoulou, C. Kourelis, and J. Meletis Pityriasis rosea associated with imatinib (STI571, Gleevec) Dermatology 205 2002 172 173
17. T. Repiso, U. Gonzalez-Castro, J. Luelmo, J. Vidal, and A. Castells Atypical pityriasis rosea in a 2-year-old Pediatr Dermatol 12 1995 63 65
18. A.B. Ackerman N. Chongchitnant J. Sanchez Y. Guo Histologic diagnosis of inflammatory skin diseases 2nd ed. 1997 Williams & Wilkins Baltimore 623 624
19. A.A. Chuh, S.S. Chiu, and J.S. Peiris Human herpes virus 6 and 7 DNA in peripheral blood leucocytes and plasma in patients with pityriasis rosea by polymerase chain reaction: a prospective case control study Acta Derm Venereol 81 2001 289 290
20. F. Loche, M.D. Thouvenin, and J. Bazex Pityriasis-rosea-like eruption due to Benfluorex Dermatology 201 2000 75
21. R. Wolf, D. Wolf, and E. Livni Pityriasis rosea and Ketotifen Dermatologica 171 1985 355 356
22. C. Buckley Pityriasis rosea-like eruption in a patient receiving omeprazole Br J Dermatol 135 1996 652 668
23. A. Lammie, M. Drojnak, W. Gerald, A. Saad, R. Cote, and C. Cordon-Cardo Expression of c-kit and kit ligands proteins in normal human tissues J Histochem Cytochem 42 1994 1417 1425